VEGFR-2 antagonists (Protelica)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameVEGFR-2 antagonists (Protelica)
Drug Alias Nameanti-VEGFR-2 antibody mimics (Protelica)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVascular endothelial growth factor modulatorsVascular endothelial growth factor receptor 2 antagonists
TargetsVascular endothelial growth factorVascular endothelial growth factor receptor 2
Therapy Area/IndicationsMacular DegenerationNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesProtelica Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesProtelica Inc
Active IndicationsN/A
Inactive IndicationsMacular DegenerationNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A